Freenome, Inc. Common stock

FRNMNASDAQ • USD
16.43 USD
↗ 0.11 (0.64%)🟢LIVE (AS OF 11:46 AM EDT)
🟢Market: OPEN

FRNM is currently priced at $16.43. The technical outlook is "Strong Buy" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages and bullish moving average alignment.

Technical & fundamental data as of Oct 2, 2026.

Open?$16.28
High?$16.62
Low?$15.98
Prev. Close?$16.32
Volume?52.3K
Avg. Volume?N/A
VWAP?$16.31
Bid / Ask
Bid?$16.28 × 100
Ask?$18.81 × 100
Spread?$2.53
Midpoint?$17.55
Valuation & Ratios
Market Cap?1.8B
Shares Out?N/A
Float?49.6M
Float %?46.2%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
Employees
N/A
Market Cap
1.8B
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2026-07-21
Address
51 ASTOR PLACE, 10TH FLOOR
NEW YORK, NY 10003
Phone: 212-284-2300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?3.42%Low
Short Interest?1.7M
Days to Cover?2.1
Free Float49.6M
Avg Daily Volume791.4K
Settlement Date2026-09-15